Literature DB >> 24902971

Inflammation and its resolution as determinants of acute coronary syndromes.

Peter Libby1, Ira Tabas2, Gabrielle Fredman2, Edward A Fisher2.   

Abstract

Inflammation contributes to many of the characteristics of plaques implicated in the pathogenesis of acute coronary syndromes. Moreover, inflammatory pathways not only regulate the properties of plaques that precipitate acute coronary syndromes but also modulate the clinical consequences of the thrombotic complications of atherosclerosis. This synthesis will provide an update on the fundamental mechanisms of inflammatory responses that govern acute coronary syndromes and also highlight the ongoing balance between proinflammatory mechanisms and endogenous pathways that can promote the resolution of inflammation. An appreciation of the countervailing mechanisms that modulate inflammation in relation to acute coronary syndromes enriches our fundamental understanding of the pathophysiology of this important manifestation of atherosclerosis. In addition, these insights provide glimpses into potential novel therapeutic interventions to forestall this ultimate complication of the disease.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  apoptosis; inflammation; inflammation resolution; macrophage; myocardial infarction; plaque necrosis

Mesh:

Year:  2014        PMID: 24902971      PMCID: PMC4078767          DOI: 10.1161/CIRCRESAHA.114.302699

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  157 in total

Review 1.  Macrophages in atherosclerosis: a dynamic balance.

Authors:  Kathryn J Moore; Frederick J Sheedy; Edward A Fisher
Journal:  Nat Rev Immunol       Date:  2013-09-02       Impact factor: 53.106

2.  Collagenases and cracks in the plaque.

Authors:  Peter Libby
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

Review 3.  Immune effector mechanisms implicated in atherosclerosis: from mice to humans.

Authors:  Peter Libby; Andrew H Lichtman; Göran K Hansson
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

Review 4.  Monocyte heterogeneity in cardiovascular disease.

Authors:  Peter Libby; Matthias Nahrendorf; Filip K Swirski
Journal:  Semin Immunopathol       Date:  2013-07-10       Impact factor: 9.623

5.  Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis.

Authors:  Ha-Na Lee; Young-Joon Surh
Journal:  Biochem Pharmacol       Date:  2013-07-12       Impact factor: 5.858

6.  Reprogramming macrophages to an anti-inflammatory phenotype by helminth antigens reduces murine atherosclerosis.

Authors:  Ine M J Wolfs; J Lauran Stöger; Pieter Goossens; Chantal Pöttgens; Marion J J Gijbels; Erwin Wijnands; Emiel P C van der Vorst; Patrick van Gorp; Linda Beckers; David Engel; Erik A L Biessen; Georg Kraal; Irma van Die; Marjo M P C Donners; Menno P J de Winther
Journal:  FASEB J       Date:  2013-09-16       Impact factor: 5.191

Review 7.  Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases.

Authors:  Matthew Spite; Joan Clària; Charles N Serhan
Journal:  Cell Metab       Date:  2013-11-14       Impact factor: 27.287

8.  Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Marcia C de Oliveira Otto; Jason H Y Wu; Ana Baylin; Dhananjay Vaidya; Stephen S Rich; Michael Y Tsai; David R Jacobs; Dariush Mozaffarian
Journal:  J Am Heart Assoc       Date:  2013-12-18       Impact factor: 5.501

9.  Local proliferation dominates lesional macrophage accumulation in atherosclerosis.

Authors:  Clinton S Robbins; Ingo Hilgendorf; Georg F Weber; Igor Theurl; Yoshiko Iwamoto; Jose-Luiz Figueiredo; Rostic Gorbatov; Galina K Sukhova; Louisa M S Gerhardt; David Smyth; Caleb C J Zavitz; Eric A Shikatani; Michael Parsons; Nico van Rooijen; Herbert Y Lin; Mansoor Husain; Peter Libby; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Nat Med       Date:  2013-08-11       Impact factor: 53.440

10.  CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation.

Authors:  Frederick J Sheedy; Alena Grebe; Katey J Rayner; Parisa Kalantari; Bhama Ramkhelawon; Susan B Carpenter; Christine E Becker; Hasini N Ediriweera; Adam E Mullick; Douglas T Golenbock; Lynda M Stuart; Eicke Latz; Katherine A Fitzgerald; Kathryn J Moore
Journal:  Nat Immunol       Date:  2013-06-30       Impact factor: 25.606

View more
  181 in total

Review 1.  Where Does Inflammation Fit?

Authors:  Luigi M Biasucci; Giulio La Rosa; Daniela Pedicino; Alessia D'Aiello; Mattia Galli; Giovanna Liuzzo
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

Review 2.  Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.

Authors:  Charles N Serhan
Journal:  FASEB J       Date:  2017-01-13       Impact factor: 5.191

Review 3.  Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.

Authors:  Mark G MacAskill; David E Newby; Adriana A S Tavares
Journal:  Cardiovasc Res       Date:  2019-12-01       Impact factor: 10.787

4.  Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes.

Authors:  Jesmond Dalli; Romain A Colas; Carolina Quintana; Diana Barragan-Bradford; Shelley Hurwitz; Bruce D Levy; Augustine M Choi; Charles N Serhan; Rebecca M Baron
Journal:  Crit Care Med       Date:  2017-01       Impact factor: 7.598

5.  A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism.

Authors:  Brenda Vincenzi; Shannon Stock; Christina P C Borba; Sarah M Cleary; Claire E Oppenheim; Liana J Petruzzi; Xiaoduo Fan; Paul M Copeland; Oliver Freudenreich; Corinne Cather; David C Henderson
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

6.  Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr-/- Mice.

Authors:  Mikyung Yu; Jaume Amengual; Arjun Menon; Nazila Kamaly; Felix Zhou; Xiaoding Xu; Phei Er Saw; Seung-Joo Lee; Kevin Si; Carleena Angelica Ortega; Won Il Choi; In-Hyun Lee; Yazan Bdour; Jinjun Shi; Morteza Mahmoudi; Sangyong Jon; Edward A Fisher; Omid C Farokhzad
Journal:  Adv Healthc Mater       Date:  2017-07-21       Impact factor: 9.933

7.  The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial.

Authors:  Abdulhamied Alfaddagh; Tarec K Elajami; Mohamad Saleh; Mohamad Elajami; Bruce R Bistrian; Francine K Welty
Journal:  J Clin Lipidol       Date:  2018-03-14       Impact factor: 4.766

Review 8.  Atherosclerosis Is an Epigenetic Disease.

Authors:  Suowen Xu; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Trends Endocrinol Metab       Date:  2018-05-10       Impact factor: 12.015

9.  Effects of Psychosocial Interventions and Caregiving Stress on Cardiovascular Biomarkers in Family Dementia Caregivers: The UCSD Pleasant Events Program (PEP) Randomized Controlled Trial.

Authors:  Roland von Känel; Paul J Mills; Joel E Dimsdale; Michael G Ziegler; Matthew A Allison; Thomas L Patterson; Sonia Ancoli-Israel; Christopher Pruitt; Igor Grant; Brent T Mausbach
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-10-15       Impact factor: 6.053

Review 10.  Delta-Like Ligand 4-Notch Signaling in Macrophage Activation.

Authors:  Toshiaki Nakano; Daiju Fukuda; Jun-Ichiro Koga; Masanori Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-08-25       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.